Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
Autoren
Kansal AR, Sharma M, Bradley-Kennedy C, Clemens A, Monz BU, Peng S, Roskell N, Sorensen SV
Journal
Thromb Haemostasis
Veröffentlichungsdatum
2012
Impact Factor
6.094
Abstract
Weitere IDs
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens